Mansoorr Mirza News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Mansoorr mirza. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Mansoorr Mirza Today - Breaking & Trending Today
Mansoor R. Mirza, MD, reviews data from the phase 3 RUBY trial investigating dostarlimab in combination with carboplatin and paclitaxel for the treatment of primary advanced or recurrent endometrial cancer. ....
TUESDAY, April 4, 2023 (HealthDay News) For patients with primary advanced or recurrent endometrial cancer, dostarlimab plus carboplatin-paclitaxel increases progression-free survival versus carboplatin-paclitaxel alone, according to a study published ....
Adding Dostarlimab Improves Progression-Free Survival in Endometrial Cancer empr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from empr.com Daily Mail and Mail on Sunday newspapers.
Adding dostarlimab to chemotherapy can improve outcomes in patients with primary advanced or recurrent endometrial cancer, a phase 3 trial suggests. ....
Adding dostarlimab to chemotherapy can improve outcomes in patients with primary advanced or recurrent endometrial cancer, a phase 3 trial suggests. ....